Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH 18/04/2019 Medications BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. Read more